| 1/5/2017 | BKCVIG | Moody’s drops St. Jude notes to Baa3
|
| 1/5/2017 | BKCVIG | Fitch lowers Abbott, St. Jude
|
| 1/5/2017 | BKCVIG | S&P lowers St. Jude Medical
|
| 4/28/2016 | BKCVIG | Fitch puts St. Jude on watch
|
| 4/28/2016 | BKCVIG | Moody’s could lower St. Jude
|
| 10/9/2015 | BKCVIG | Moody’s lowers St. Jude
|
| 10/8/2015 | BKCVIG | S&P downgrades St. Jude
|
| 9/17/2015 | BKCVIG | S&P: St. Jude on watch on acquisition news
|
| 9/14/2015 | BKCVIG | S&P rates St. Jude Medical notes A, places on watch
|
| 9/14/2015 | BKCVIG | Fitch lowers St. Jude, rates notes A-
|
| 9/14/2015 | BKCVIG | Moody’s rates St. Jude notes, loans Baa2
|
| 8/28/2015 | CVIG | S&P rates St. Jude loan A
|
| 7/22/2015 | CVIG | Fitch puts St. Jude on watch
|
| 7/22/2015 | CVIG | S&P: St. Jude Medical on negative watch
|
| 7/22/2015 | CV | S&P: St. Jude Medical on negative watch
|
| 7/22/2015 | CV | S&P: St. Jude Medical on negative watch
|
| 3/21/2013 | CVIG | S&P rates St. Jude notes A
|
| 3/21/2013 | CVIG | Moody's: St. Jude notes Baa1
|
| 10/13/2011 | CVIG | Fitch affirms St. Jude
|
| 12/1/2010 | CVIG | S&P rates St. Jude notes A
|
| 12/1/2010 | CVIG | Fitch rates St. Jude, notes A
|
| 12/1/2010 | CVIG | Moody's: St. Jude note at Baa1
|
| 7/22/2009 | CVIG | St. Jude Medical files shelf registration covering debt, preferreds
|
| 7/17/2009 | CVIG | Fitch rates St. Jude A
|
| 7/16/2008 | CV | Market Commentary: Alpha Natural merger hurts hedge funds; financials rebound; St. Jude up on results; Trina Solar plans deal
|
| 1/24/2008 | CVIG | S&P: St. Jude view positive
|
| 1/9/2008 | CV | Market Commentary: Countrywide, REITs head lower; financials, health care in focus; market pares early losses; Thornburg plans deal
|
| 10/23/2007 | CV | Market Commentary: Level 3 hammered on earnings; Countrywide down on borrower bailout; Medtronic coming back?
|
| 10/19/2007 | CV | Market Commentary: Gilead falls after positive earnings; Medtronic drags down St. Jude; AMD weighs down Intel; Yahoo! gives back
|
| 10/18/2007 | CV | Market Commentary: CIT active but stays still; Medtronic continues slide; St. Jude down; Nektar tumbles as Pfizer pulls drug
|
| 9/27/2007 | CV | Market Commentary: General Cable well-received; GM, Ford slip; AMR flies high on Icelandic air; St. Jude, LifePoint up
|
| 7/25/2007 | CV | Convertible analyst Berkman identifies safe harbors in choppy market seas
|
| 4/30/2007 | CV | Market Commentary: Tyco continues gains amid tender offer; MedImmune up ahead of earnings; issuance grows in April
|
| 4/20/2007 | CV | Market Commentary: St. Jude gains on debut; BankUnited slips with stock; Delta Petroleum quiet; Archer Daniels better to sell
|
| 4/20/2007 | CV | New Issue: St. Jude prices $1.2 billion 20-month convertibles within talk at 1.22%, up 20%
|
| 4/19/2007 | CV | St. Jude Medical prices $1.2 billion 20-month convertibles at 1.22%, up 20%, greenshoe exercised
|
| 4/19/2007 | CV | S&P gives St. Jude Medical convertibles BBB+
|
| 4/19/2007 | CV | Market Commentary: Linear gains on debut; Delta improves, BankUnited slips, St. Jude quiet in gray; International Game eases
|
| 10/18/2006 | CV | Market Commentary: St. Jude flat, drags Medtronic lower; AMR gains on profit; Home Properties, Minefinders quiet in the gray
|
| 9/14/2006 | CV | New Issue: Eksportfinans sells $1 million 9% notes linked to St. Jude Medical
|
| 8/3/2006 | CV | Market Commentary: Medtronic, DRS fall outright on poor guidance; Transocean slides on miss; CompuCredit declines
|
| 8/2/2006 | CV | Market Commentary: Ford revs up on new advisor; Medtronic, St. Jude gain on Medicare changes; Huntsman gets results boost
|
| 4/20/2006 | BTCV | S&P: St. Jude Medical unaffected
|
| 4/20/2006 | CV | Market Commentary: General Motors gains, Intel falls on quarterly results; Gilead new deal stumbles on debut;
|
| 12/7/2005 | BTCV | S&P rates St. Jude convertibles BBB+
|
| 12/7/2005 | CV | Market Commentary: XL Capital, Aspen Insurance, St. Jude lift slightly; SafeNet prices; Calpine grinds lower
|
| 12/6/2005 | CV | Market Commentary: Kansas City Southern gains on debut; U.S. Bancorp steady after re-offer; St. Jude Medical prices
|
| 12/6/2005 | BTCV | New Issue: St. Jude Medical $600 million 30-year convertibles yield 2.8%, up 25%
|
| 12/5/2005 | CV | Market Commentary: U.S. Bancorp brings $2 billion; Kansas City Southern, St. Jude, Omnicare also launch; Calpine down
|
| 12/5/2005 | BTCV | St. Jude Medical $600 million 30-year convertibles talked to yield 2.375%-2.875%, up 25%
|
